Sorrisos: O=C1/C(C)=C\C=C\C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C(OC)/C=C/OC2(C)OC3=C(C2=O)C4=C(C(O)=C3C)C(C)=C(C(/C=N/N5CCN(C)CC5)=C4O)N1
Inchi: InChI=1S/C19H31NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h7-12,21-22H,2-6,13-16,20H2,1H3/b8-7+
Structural elucidation of the Rifaximin Ph. Eur. Impurity H
Riccardo Stradi, Donatella Nava, Marino Nebuloni, Barbara Pastura, ElenaPini
Journal of Pharmaceutical and Biomedical Analysis Volume 51, Issue 4, 11 March 2010, Pages 858-865
Structure Elucidation of Two Unknown Oxydic Degradation Impurities of Rifaximin
chao liu, chang-qin hu and shao-hong jin
Asian Journal of Chemistry; Vol. 23, No. 7 (2011), 3252-3256
Development and validation of rp-hplc method for the estimation of rifaximin in bulk and in tablet dosage form
T.sudha, P.V.hemalatha, V.R.ravikumar,r.jothi, M.radhakrishnan
Asian Journal of Pharmaceutical and Clinical Research Vol.2 Issue 4, October-December 2009
Stability Indicating HPTLC Method for Analysis of Rifaximin in Pharmaceutical Formulations and an Application to Acidic Degradation Kinetic Study
Kalpana G. Patel , Nitesh R. Jain, and Purvi A. Shah
Hindawi Publishing Corporation ISRN Analytical Chemistry Volume 2013, Article ID 613218, 9 pages